Papillary serous carcinoma of the peritoneum coexisting with or after endometrial carcinoma

Gynecologic Oncology

Volumn 84, Issue 2, 2002, Pages 245-251

  Altaras, Marco M ^a,b   Bernheim, Joelle ^a,b   Zehavi, Tania ^a,b   Fishman, Ami ^a,b  

^a MEIR MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Endometrial carcinomas; Papillary serous carcinomas; Peritoneum

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CLINICAL ARTICLE; DNA REPAIR; ENDOMETRIUM CARCINOMA; FAMILY HISTORY; FEMALE; GENE EXPRESSION REGULATION; GENE MUTATION; GERM LINE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; PAPILLARY CARCINOMA; PERITONEUM TUMOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 0036172957     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2001.6492     Document Type: Article

References (36)

1. Extra-ovarian peritoneal serous papillary carcinoma: A case-control retrospective comparison to papillary adenocarcinomas of the ovary
2. Annual report on the results of treatment in gynecological cancer
3. Mesothelioma of the peritoneum resembling papillary cystadenoma of the ovary. Case report
4. Papillary tumors of the peritoneum in women: Mesothelioma or papillary carcinoma
5. BRCA1 gene mutations in women with papillary serous carcinoma of the peritoneum
6. The ovarian mesothelioma
7. Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serous carcinomas
8. Familial peritoneal ovarian carcinomatosis: A new clinical entity?
9. Primary peritoneal papillary serous adenocarcinoma: Clinical and management aspects
10. Prognostic factors in extraovarian primary peritoneal carcinoma
11. Primary peritoneal serous papillary carcinoma: A study of 25 cases and comparison with stage III-IV ovarian papillary serous carcinoma
12. Laparoscopic diagnosis of peritoneal serous papillary carcinoma
13. Peritoneal serous papillary carcinoma. A phenotypic variant of familial ovarian cancer: Implication for ovarian cancer screening
14. Hereditary ovarian cancer. Pedigree studies. Part II
15. Patients with double primary tumors in the breast and ovary. Clinical characteristics and BRCA1 mutations status
16. Papillary serous carcinoma of the peritoneum following endometrial cancer
17. Familial papillary serous carcinoma of the cervix, peritoneum and ovary. A report of the first case
18. Biomarker conservation in primary and metastatic epithelial ovarian cancer
19. Role of p53 alteration in primary peritoneal cancer
20. p53 expression in neoplasms of the uterine corpus
21. Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage disease
22. HER-2/neu expression: A major prognostic factor in endometrial cancer
23. Bcl-2 expression in endometrial hyperplasia and carcinoma
24. Molecular events in endometrial carcinogenesis
25. Multiple primary malignant tumors
26. Multiple primary gynecologic neoplasms
27. Immunocytochemical assay for receptor in patients with breast cancer: Relationship to a biochemical assay and to outcome of therapy
28. Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations
29. A second primary malignancy in a cohort of patients with epithelial ovarian cancer - Characteristics of diagnosis
30. Multifocal disease in the upper genital canal
31. The relationship between borderline ovarian tumors and epithelial ovarian carcinoma. Epidemiologic pathologic and molecular aspects
32. Epithelial ovarian tumors of low malignant potential
33. Molecular genetic evidence of a unifocal origin for human serous ovarian carcinomas
34. BRCA1, BRCA2 and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: Rrelationship to family history and implications for genetic testing
35. Oncogenes and tumor suppressor genes